bill718
Diamond Member
- Jun 26, 2016
- 1,225
- 2,394
- 1,940
A Seattle researcher who’s studying a coronavirus vaccine undergoing clinical trials is pleased with early results that show the vaccine mounts an immune response.
“Seeing this is just wonderful,” said Dr. John Dunn, a researcher with the Kaiser Permanente Washington Health Research Institute in Seattle. Dunn said so far there’s no serious safety concerns with the vaccine, which is given in two shots, a month apart. One of the participants, Neal Browning of Bothell, WA said he did experience a little soreness at the injection site the morning after he received a dose but that only lasted a few minutes. “Much like you'd get when you had a typical flu shot,” Browning said.
We're not out of the woods on this virus, but progress is being made.
“Seeing this is just wonderful,” said Dr. John Dunn, a researcher with the Kaiser Permanente Washington Health Research Institute in Seattle. Dunn said so far there’s no serious safety concerns with the vaccine, which is given in two shots, a month apart. One of the participants, Neal Browning of Bothell, WA said he did experience a little soreness at the injection site the morning after he received a dose but that only lasted a few minutes. “Much like you'd get when you had a typical flu shot,” Browning said.
We're not out of the woods on this virus, but progress is being made.
